Article

Machine learning predicts rapid relapse of triple negative breast cancer

2019-04-21

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Purpose</h4> Metastatic relapse of triple-negative breast cancer (TNBC) within 2 years of diagnosis is associated with particularly aggressive disease and a distinct clinical course relative to TNBCs that relapse beyond 2 years. We hypothesized that rapid relapse TNBCs (rrTNBC; metastatic relapse or death <2 years) reflect unique genomic features relative to late relapse (lrTNBC; >2 years)....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1bb3e1e1-b7a5-5fd5-8bb3-701395b24d12
DOI: 10.1101/613604

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Machine learning predicts rapid relapse of triple negative breast cancerDOI 10.1101/613604Read

Genomic Features of Rapid Versus Late Relapse in Triple Negative Breast Cancer Semantic proximity Read

Genomic features of rapid versus late relapse in triple negative breast cancer.Semantic proximity Read

Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity Read

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read

The Early-Stage Triple-Negative Breast Cancer Landscape Derives a Novel Prognostic Signature and Therapeutic TargetSemantic proximity Read

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity Read

Dynamic ctDNA tracking stratifies individual relapse risk for early triple negative breast cancer patients receiving neoadjuvant chemotherapySemantic proximity Read

Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.Semantic proximity Read

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesSemantic proximity Read

Proteogenomics decodes the evolution of human ipsilateral breast cancerSemantic proximity Read

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read

Comparison of time-varying recurrence patterns in breast cancer patients with different molecular subtypes treated from 2008 to 2012 and from 2013 to 2016: a single-center retrospective studySemantic proximity Read